Clinical Trial Update: A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 trial of trimetrexate with leucovorin rescue for AIDS patients with Pneumocystis jirovecii pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Pneumocystis Jirovecii Pneumonia

Drugs mentioned

• Leucovorin (folinic acid)
• Trimetrexate (trimetrexate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Status: COMPLETED